These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 13159444

  • 1. [The action of 1,4-bis(2-diethylaminoethyl)-piperazine dibromobenzylate (isocurine) on cholinergic structures].
    PHILIPPOT E, DALLEMAGNE J.
    Arch Int Pharmacodyn Ther; 1954 Jan; 96(3-4):485-6. PubMed ID: 13159444
    [No Abstract] [Full Text] [Related]

  • 2. The influence of chlorpromazine on neuromuscular transmission and on the action of muscle relaxants.
    WISLICKI L.
    Arch Int Pharmacodyn Ther; 1958 May 01; 115(1-2):52-61. PubMed ID: 13545886
    [No Abstract] [Full Text] [Related]

  • 3. [Action of dicarnitine on cholinergic structures].
    PHILIPPOT E, DALLEMAGNE MJ, DUMOULIN EL.
    Arch Int Pharmacodyn Ther; 1954 Jun 01; 98(2):245-50. PubMed ID: 13198308
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacology of 3,6 bis(3-diethyl-aminopropoxy) pyridazine bis-methiodide, a hemicholinium-like agent.
    GESLER RM, HOPPE JO.
    Fed Proc; 1961 Jul 01; 20():587-93. PubMed ID: 13704814
    [No Abstract] [Full Text] [Related]

  • 5. The neuromuscular blocking properties of alpha, alpha, dimethylethanolamino 4,4' biacetophenone (hemicholinium).
    REITZEL NL, LONG JP.
    Arch Int Pharmacodyn Ther; 1959 Mar 01; 119(1-2):20-30. PubMed ID: 13628264
    [No Abstract] [Full Text] [Related]

  • 6. Speed of action of various muscle relaxants at the neuromuscular junction binding vs. buffering hypothesis.
    Glavinovic MI, Law Min JC, Kapural L, Donati F, Bevan DR.
    J Pharmacol Exp Ther; 1993 Jun 01; 265(3):1181-6. PubMed ID: 8510002
    [Abstract] [Full Text] [Related]

  • 7. The action of ambenonium (WIN 8077) and related compounds in the mouse.
    LANDS AM, HOPPE JO, KARCZMAR AG, ARNOLD A.
    J Pharmacol Exp Ther; 1957 Apr 01; 119(4):541-9. PubMed ID: 13429462
    [No Abstract] [Full Text] [Related]

  • 8. [Influence of N1-p-chlorophenyl-N5-isopropylbiguanide (paludrine) and its metabolite on myoneural transmission].
    DALLEMAGNE MJ, PHILIPPOT E.
    Arch Int Pharmacodyn Ther; 1954 Jan 01; 96(3-4):482-4. PubMed ID: 13159443
    [No Abstract] [Full Text] [Related]

  • 9. [Histochemical studies on the psychomotor end plate of the skeletal muscles on the white mouse after administration of the cholinesterase inhibitors BC 16 (hexamethylene-bis-carbaminoylcholine) and BC 47 (octamethylene-bis-carbaminoyl-m-trimethylammoniumphenol)].
    KOVAC W, KRAUPP O, LASSMANN G.
    Acta Neuroveg (Wien); 1955 Jan 01; 12(3):329-34. PubMed ID: 13301597
    [No Abstract] [Full Text] [Related]

  • 10. [Mechanism of action of myoneural blockinducing drugs and their antagonists].
    HUIDOBRO F.
    Arzneimittelforschung; 1960 Dec 01; 10():967-71. PubMed ID: 13716710
    [No Abstract] [Full Text] [Related]

  • 11. [Relation between the structure of bis-(halogen-trimethylaminophenoxy)-alkanes and arylalkanes and their action on neuromuscular transmission].
    DEPIERRE F, FUNKE A.
    C R Hebd Seances Acad Sci; 1952 Jul 21; 235(3):267-9. PubMed ID: 13009912
    [No Abstract] [Full Text] [Related]

  • 12. [Site of action of muscle relaxants. Aspects of the transmission at the level of the neuromuscular junction].
    Galindo A.
    Rev Bras Anestesiol; 1971 Jul 21; 21(3):296-301. PubMed ID: 4333103
    [No Abstract] [Full Text] [Related]

  • 13. The neuromuscular junction. Part I: physiology and the effects of drugs and toxins.
    Brumback RA.
    Am Fam Physician; 1981 Jan 21; 23(1):188-92. PubMed ID: 7457314
    [Abstract] [Full Text] [Related]

  • 14. On the mechanism of action of bis-(8'-quinoliloxy) 1.5-pentane di-iodo ethylate (3381 RP) on the neuro-muscular junction.
    HUIDOBRO F.
    Acta Physiol Lat Am; 1955 Jan 21; 5(1):46-7. PubMed ID: 14398308
    [No Abstract] [Full Text] [Related]

  • 15. A partial pharmacologic profile of the response to neuromuscular blocking agents as modified by sodium L-thyroxine.
    TABACHNICK II, THORSTAD JA, WAGNER J, PARKER RF.
    Arch Int Pharmacodyn Ther; 1958 Mar 01; 114(2):210-6. PubMed ID: 13534812
    [No Abstract] [Full Text] [Related]

  • 16. Differences in mode of neuromuscular blockade in a series of symmetric bis-quaternary ammonium salts.
    THESLEFF S, UNNA KR.
    J Pharmacol Exp Ther; 1954 May 01; 111(1):99-113. PubMed ID: 13163849
    [No Abstract] [Full Text] [Related]

  • 17. [Changes in the reactivity of the anterior tibial muscle in cats following action of some piperazine derivatives].
    Angelov A, Sikolova S.
    Eksp Med Morfol; 1974 May 01; 13(1):45-50. PubMed ID: 4365043
    [No Abstract] [Full Text] [Related]

  • 18. The effect of histamine on neuromyal blocking agents.
    SCHENK EA, ANDERSON EG.
    J Pharmacol Exp Ther; 1958 Feb 01; 122(2):234-8. PubMed ID: 13514611
    [No Abstract] [Full Text] [Related]

  • 19. The effect of tetraethylammonium (TEA) and temperature on the neuromuscular block produced by magnesium.
    STOVNER J.
    Acta Physiol Scand; 1957 Dec 31; 41(4):370-83. PubMed ID: 13497782
    [No Abstract] [Full Text] [Related]

  • 20. The morphology of the myoneural junction as influenced by neurotoxic drugs.
    HARRIS C.
    Am J Pathol; 1954 Dec 31; 30(3):501-19. PubMed ID: 13158524
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.